Glucagon is associated with NAFLD inflammatory progression in type 2 diabetes, not with NAFLD fibrotic progression

OBJECTIVES: Higher prevalence of progressive stages of nonalcoholic fatty liver disease (NAFLD) and hyperglucagonemia were observed in type 2 diabetes. We aim to investigate whether islet alpha cell dysfunction (evaluated by glucagon) associates with NAFLD progression in type 2 diabetic adults. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuying, Lin, Zhiqi, Wan, Heng, Zhang, Wen, Xia, Fangzhen, Chen, Yi, Chen, Xiaoman, Wang, Chiyu, Chen, Chi, Wang, Ningjian, Lu, Yingli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2021
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734619/
https://www.ncbi.nlm.nih.gov/pubmed/34402473
http://dx.doi.org/10.1097/MEG.0000000000002269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734619/
https://www.ncbi.nlm.nih.gov/pubmed/34402473
http://dx.doi.org/10.1097/MEG.0000000000002269

Ejemplares similares